Industry news that matters to you.  Learn more

Archives for November 2010

Caris Life Sciences Expands Caris Target Now Biomarker Panel to Help Address Therapeutic Dilemmas Facing Nearly One Half of Breast Cancer Patients

Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced a significant expansion to the panel of breast cancer biomarkers analyzed by Caris Target Now. The expansion includes 14 new biomarkers that provide physicians with key information to help guide therapeutic decisions for an increased number of breast cancer patients, making the novel theranostic tool now potentially useful to approximately 50 percent of all women battling the disease.

Metabolon Awarded US Patent for Metabolic Biomarkers of Efficacy of Peroxisome Proliferator Activated Receptor (PPAR) Affecting Drugs

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled “Biomarkers of Metabolic Responses to Hepatic Drugs”. The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.